Functional genomics has provided evidence that the human genome transcribes a large
number of non-coding genes in addition to protein-coding genes, including microRNAs and …

Thyroid cancer remains the most prevailing endocrine malignancy, and a progressively
increasing incidence rate has been observed in recent years, with 95% of thyroid cancer …

Background Papillary thyroid carcinoma (PTC) is a common endocrine neoplasm with a
recent increase in incidence in many countries. Although PTC has been explored by gene …

Recent advances in the arena of theranostics have necessitated a re-examining of
previously established fields. The existing paradigm of therapeutic thyroid-stimulating …

Background Previous literatures showed wide range of prevalence of BRAF V600E in
papillary thyroid carcinoma (PTC). The correlation of BRAF V600E mutation with aggressive …

Lymph node metastasis (LNM) in papillary thyroid cancer (PTC) is related to increased risk
of recurrence and poor prognosis. Tumour exosomes have been shown to be associated …

Papillary thyroid cancer (PTC) is a prevalent kind of thyroid cancer (TC), with the risk of
metastasis increasing faster than any other malignancy. So, understanding the role of PTC …

Simple Summary Thyroid tumors represent the most common neoplastic pathology of the
endocrine system. Mutations occurring in oncogenes and tumor suppressor genes are …

Immunohistochemistry (IHC) in evaluating thyroid surgical specimens may facilitate
diagnostic and prognostic evaluation, with potential therapeutic implications. We performed …

Abstract BRAF V600E mutation has been thought to be a valuable molecular marker that
may predict a worse prognosis for papillary thyroid cancer (PTC). But whether BRAF V600E …